重仓股明细
查询指定年度的基金持仓:
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
09926 |
康方生物 |
10.35% |
567.56 |
65246.42 |
0.62% |
4.81 (0.85%) |
| 2 |
688331 |
荣昌生物 |
9.61% |
470.51 |
60587.69 |
2.88% |
3.12 (0.66%) |
| 3 |
06990 |
科伦博泰生物 |
8.07% |
125.38 |
50923.56 |
0.77% |
-12.23 (-9.75%) |
| 4 |
01801 |
信达生物 |
8.06% |
678.18 |
50837.93 |
0.39% |
-63.20 (-9.32%) |
| 5 |
600276 |
恒瑞医药 |
7.88% |
899.91 |
49692.90 |
0.14% |
-16.64 (-1.85%) |
| 6 |
688235 |
百济神州 |
7.30% |
197.04 |
46027.25 |
1.71% |
-2.90 (-1.47%) |
| 7 |
002755 |
奥赛康 |
7.16% |
2882.62 |
45141.78 |
3.11% |
-222.72 (-7.73%) |
| 8 |
688192 |
迪哲医药 |
5.01% |
583.16 |
31601.35 |
1.27% |
-23.52 (-4.03%) |
| 9 |
603259 |
药明康德 |
4.43% |
285.01 |
27959.03 |
0.12% |
新增 |
| 10 |
09606 |
映恩生物-B |
4.26% |
103.16 |
26870.11 |
1.14% |
新增 |
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
09926 |
康方生物 |
10.35% |
567.56 |
65246.42 |
0.62% |
4.81 (0.85%) |
| 2 |
688331 |
荣昌生物 |
9.61% |
470.51 |
60587.69 |
2.88% |
3.12 (0.66%) |
| 3 |
06990 |
科伦博泰生物 |
8.07% |
125.38 |
50923.56 |
0.77% |
-12.23 (-9.75%) |
| 4 |
01801 |
信达生物 |
8.06% |
678.18 |
50837.93 |
0.39% |
-63.20 (-9.32%) |
| 5 |
600276 |
恒瑞医药 |
7.88% |
899.91 |
49692.90 |
0.14% |
-16.64 (-1.85%) |
| 6 |
688235 |
百济神州 |
7.30% |
197.04 |
46027.25 |
1.71% |
-2.90 (-1.47%) |
| 7 |
002755 |
奥赛康 |
7.16% |
2882.62 |
45141.78 |
3.11% |
-222.72 (-7.73%) |
| 8 |
688192 |
迪哲医药 |
5.01% |
583.16 |
31601.35 |
1.27% |
-23.52 (-4.03%) |
| 9 |
603259 |
药明康德 |
4.43% |
285.01 |
27959.03 |
0.12% |
新增 |
| 10 |
09606 |
映恩生物-B |
4.26% |
103.16 |
26870.11 |
1.14% |
新增 |
显示全部持仓明细>>
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
09926 |
康方生物 |
9.68% |
562.74 |
57435.80 |
0.61% |
新增 |
| 2 |
600276 |
恒瑞医药 |
9.21% |
916.55 |
54598.74 |
0.14% |
新增 |
| 3 |
688235 |
百济神州 |
9.06% |
199.95 |
53705.84 |
1.74% |
新增 |
| 4 |
01801 |
信达生物 |
8.61% |
741.38 |
51059.13 |
0.43% |
676.58 (91.26%) |
| 5 |
002755 |
奥赛康 |
8.55% |
3105.34 |
50710.15 |
3.35% |
新增 |
| 6 |
06990 |
科伦博泰生物 |
8.22% |
137.61 |
48747.01 |
0.85% |
124.75 (90.65%) |
| 7 |
688506 |
百利天恒 |
7.74% |
142.03 |
45888.73 |
1.38% |
新增 |
| 8 |
688331 |
荣昌生物 |
6.13% |
467.39 |
36358.55 |
2.88% |
新增 |
| 9 |
688192 |
迪哲医药 |
5.89% |
606.68 |
34944.70 |
1.33% |
新增 |
| 10 |
01530 |
三生制药 |
5.30% |
1438.72 |
31421.41 |
0.57% |
新增 |
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
09926 |
康方生物 |
9.68% |
562.74 |
57435.80 |
0.61% |
新增 |
| 2 |
600276 |
恒瑞医药 |
9.21% |
916.55 |
54598.74 |
0.14% |
新增 |
| 3 |
688235 |
百济神州 |
9.06% |
199.95 |
53705.84 |
1.74% |
新增 |
| 4 |
01801 |
信达生物 |
8.61% |
741.38 |
51059.13 |
0.43% |
676.58 (91.26%) |
| 5 |
002755 |
奥赛康 |
8.55% |
3105.34 |
50710.15 |
3.35% |
新增 |
| 6 |
06990 |
科伦博泰生物 |
8.22% |
137.61 |
48747.01 |
0.85% |
124.75 (90.65%) |
| 7 |
688506 |
百利天恒 |
7.74% |
142.03 |
45888.73 |
1.38% |
新增 |
| 8 |
688331 |
荣昌生物 |
6.13% |
467.39 |
36358.55 |
2.88% |
新增 |
| 9 |
688192 |
迪哲医药 |
5.89% |
606.68 |
34944.70 |
1.33% |
新增 |
| 10 |
01530 |
三生制药 |
5.30% |
1438.72 |
31421.41 |
0.57% |
新增 |
显示全部持仓明细>>
| 季报日期: 2024-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
8.88% |
64.80 |
2176.41 |
9.61% |
-7.90 (-12.19%) |
| 2 |
00013 |
和黄医药 |
8.19% |
80.01 |
2008.12 |
8.86% |
-18.65 (-23.31%) |
| 3 |
06990 |
科伦博泰生物-B |
7.94% |
12.86 |
1946.01 |
8.59% |
新增 |
| 4 |
03692 |
翰森制药 |
4.75% |
78.20 |
1164.78 |
5.14% |
新增 |
| 5 |
06160 |
百济神州 |
4.43% |
13.80 |
1085.69 |
4.79% |
新增 |
| 6 |
01177 |
中国生物制药 |
4.23% |
425.00 |
1035.66 |
4.57% |
-101.60 (-23.91%) |
| 季报日期: 2024-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
8.88% |
64.80 |
2176.41 |
9.61% |
-7.90 (-12.19%) |
| 2 |
00013 |
和黄医药 |
8.19% |
80.01 |
2008.12 |
8.86% |
-18.65 (-23.31%) |
| 3 |
06990 |
科伦博泰生物-B |
7.94% |
12.86 |
1946.01 |
8.59% |
新增 |
| 4 |
03692 |
翰森制药 |
4.75% |
78.20 |
1164.78 |
5.14% |
新增 |
| 5 |
06160 |
百济神州 |
4.43% |
13.80 |
1085.69 |
4.79% |
新增 |
| 6 |
01177 |
中国生物制药 |
4.23% |
425.00 |
1035.66 |
4.57% |
-101.60 (-23.91%) |
显示全部持仓明细>>
| 季报日期: 2023-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
8.47% |
72.70 |
2816.46 |
9.12% |
48.35 (66.51%) |
| 2 |
00013 |
和黄医药 |
7.71% |
98.66 |
2565.97 |
8.31% |
52.70 (53.42%) |
| 3 |
02162 |
康诺亚-B |
6.49% |
48.51 |
2158.68 |
6.99% |
35.86 (73.93%) |
| 4 |
09926 |
康方生物 |
5.17% |
40.93 |
1721.19 |
5.57% |
20.10 (49.10%) |
| 5 |
01177 |
中国生物制药 |
4.98% |
526.60 |
1655.94 |
5.36% |
426.40 (80.97%) |
| 6 |
01548 |
金斯瑞生物科技 |
4.87% |
90.01 |
1619.96 |
5.24% |
52.41 (58.23%) |
| 7 |
09995 |
荣昌生物 |
4.57% |
44.80 |
1520.42 |
4.92% |
新增 |
| 8 |
02096 |
先声药业 |
0.04% |
2.00 |
12.20 |
0.04% |
-66.20 (-3310.00%) |
| 季报日期: 2023-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
8.47% |
72.70 |
2816.46 |
9.12% |
48.35 (66.51%) |
| 2 |
00013 |
和黄医药 |
7.71% |
98.66 |
2565.97 |
8.31% |
52.70 (53.42%) |
| 3 |
02162 |
康诺亚-B |
6.49% |
48.51 |
2158.68 |
6.99% |
35.86 (73.93%) |
| 4 |
09926 |
康方生物 |
5.17% |
40.93 |
1721.19 |
5.57% |
20.10 (49.10%) |
| 5 |
01177 |
中国生物制药 |
4.98% |
526.60 |
1655.94 |
5.36% |
426.40 (80.97%) |
| 6 |
01548 |
金斯瑞生物科技 |
4.87% |
90.01 |
1619.96 |
5.24% |
52.41 (58.23%) |
| 7 |
09995 |
荣昌生物 |
4.57% |
44.80 |
1520.42 |
4.92% |
新增 |
| 8 |
02096 |
先声药业 |
0.04% |
2.00 |
12.20 |
0.04% |
-66.20 (-3310.00%) |
显示全部持仓明细>>
| 季报日期: 2023-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
00013 |
和黄医药 |
4.82% |
45.96 |
781.36 |
5.29% |
43.91 (95.54%) |
| 2 |
09926 |
康方生物 |
4.19% |
20.83 |
679.00 |
4.60% |
19.73 (94.72%) |
| 3 |
01801 |
信达生物 |
4.10% |
24.35 |
664.53 |
4.50% |
22.15 (90.97%) |
| 4 |
01548 |
金斯瑞生物科技 |
3.77% |
37.60 |
610.13 |
4.13% |
新增 |
| 5 |
02096 |
先声药业 |
3.01% |
68.20 |
487.94 |
3.30% |
新增 |
| 6 |
02162 |
康诺亚-B |
2.95% |
12.65 |
477.02 |
3.23% |
新增 |
| 7 |
03692 |
翰森制药 |
2.87% |
40.00 |
464.68 |
3.15% |
新增 |
| 8 |
02269 |
药明生物 |
2.49% |
11.65 |
403.33 |
2.73% |
新增 |
| 9 |
06855 |
亚盛医药-B |
2.09% |
17.44 |
339.27 |
2.30% |
新增 |
| 10 |
02171 |
科济药业-B |
2.04% |
36.95 |
330.11 |
2.23% |
新增 |
| 季报日期: 2023-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
00013 |
和黄医药 |
4.82% |
45.96 |
781.36 |
5.29% |
43.91 (95.54%) |
| 2 |
09926 |
康方生物 |
4.19% |
20.83 |
679.00 |
4.60% |
19.73 (94.72%) |
| 3 |
01801 |
信达生物 |
4.10% |
24.35 |
664.53 |
4.50% |
22.15 (90.97%) |
| 4 |
01548 |
金斯瑞生物科技 |
3.77% |
37.60 |
610.13 |
4.13% |
新增 |
| 5 |
02096 |
先声药业 |
3.01% |
68.20 |
487.94 |
3.30% |
新增 |
| 6 |
02162 |
康诺亚-B |
2.95% |
12.65 |
477.02 |
3.23% |
新增 |
| 7 |
03692 |
翰森制药 |
2.87% |
40.00 |
464.68 |
3.15% |
新增 |
| 8 |
02269 |
药明生物 |
2.49% |
11.65 |
403.33 |
2.73% |
新增 |
| 9 |
06855 |
亚盛医药-B |
2.09% |
17.44 |
339.27 |
2.30% |
新增 |
| 10 |
02171 |
科济药业-B |
2.04% |
36.95 |
330.11 |
2.23% |
新增 |
| 11 |
01177 |
中国生物制药 |
1.94% |
100.20 |
315.02 |
2.13% |
--- |
| 12 |
09688 |
再鼎医药 |
1.92% |
16.06 |
310.95 |
2.10% |
--- |
显示全部持仓明细>>
| 季报日期: 2022-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
5.41% |
2.20 |
65.83 |
5.68% |
--- |
| 2 |
00013 |
和黄医药 |
3.61% |
2.05 |
43.95 |
3.79% |
--- |
| 3 |
09926 |
康方生物 |
3.47% |
1.10 |
42.25 |
3.65% |
--- |
| 4 |
09966 |
康宁杰瑞制药-B |
3.33% |
4.20 |
40.52 |
3.50% |
--- |
| 季报日期: 2022-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
5.41% |
2.20 |
65.83 |
5.68% |
--- |
| 2 |
00013 |
和黄医药 |
3.61% |
2.05 |
43.95 |
3.79% |
--- |
| 3 |
09926 |
康方生物 |
3.47% |
1.10 |
42.25 |
3.65% |
--- |
| 4 |
09966 |
康宁杰瑞制药-B |
3.33% |
4.20 |
40.52 |
3.50% |
--- |
显示全部持仓明细>>